-
Medical journals
- Career
Clinical Oncology - Issue 3/2024
Editorial
159
Reviews
164Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022Z. Adam, M. Hermanová, T. Horváth, L. Pour, S. Ševčíková, K. Starý, M. Dastych, Z. Řehák, Z. Adamová, Z. Král
178Barriers and supportive factors in engaging cancer patients in physical activity programmes – a literature reviewI. Burešová, J. Halámková, I. Kiss, K. Kapounková, I. Hrnčiříková
184A novel approach to cancer screening using the nematode Caenorhabditis elegans-based detection assaysA. Kaiglová, S. Kucharíková
Original Articles
189Results of the study of factors predicting the risk of the development of grade III radiation-induced mucositis during radiation or chemoradiation therapy in patients with oral cavity and oropharynx cancerH. A. Hirna, D. V. Maltsev, I. D. Kostyshyn, V. V. Holotiuk
202Survival outcomes and failure patterns for oropharyngeal cancers treated with simultaneous integrated boost in intensity modulated radiotherapy (SIB-IMRT) and concurrent chemotherapyV. Shivhare, S. Rath, I. B. Shah, N. K. Dash, A. Parikh, U. S. Kunikullaya
Case Reports
209Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions – a case report and a literature reviewZ. Adam, Z. Řehák, M. Keřkovský, C. Povýšil, E. Ezer, A. Buliková, L. Pour, M. Doubek, Y. Stavařová, L. Zdražilová Dubská, P. Szutyany, S. Ševčíková, Z. Král
Oncology Highlights
220Novinky v léčbě renálního karcinomu a metastatického uroteliálního karcinomuA. Poprach, T. Büchler
Reports from the literature
Clinical Oncology
2024 Issue 3
Most read in this issue- Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022
- A novel approach to cancer screening using the nematode Caenorhabditis elegans-based detection assays
- Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions – a case report and a literature review
- Results of the study of factors predicting the risk of the development of grade III radiation-induced mucositis during radiation or chemoradiation therapy in patients with oral cavity and oropharynx cancer
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career